Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-cancer agents and new combinations of such drugs

Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-cancer agents and new combinations of such drugs

US Patent 11744827 · Granted Sep 5, 2023

Estimated economic value: $716,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chemicals and methods to prevent and treat TGF-beta mediated activation of fibro2021
Isothiocyanatostilbenes as a novel method and product for treating cancer2021
Methods for treating c-Met-dependent cancers2021
Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-c2020
Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-c2020
Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-c2020
Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-c2020
Cancer treatment combination compositions, methods and uses2020